| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/09/1993 | EP0544815A1 Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates |
| 06/09/1993 | EP0544743A1 Lymphokine 154 |
| 06/09/1993 | EP0544719A1 Cytokine production |
| 06/09/1993 | EP0544716A1 Oligonucleotide modulation of cell adhesion |
| 06/09/1993 | EP0544706A1 Histidine substituted growth hormone releasing factor analogs |
| 06/09/1993 | EP0500695A4 Gnrh analogs |
| 06/09/1993 | EP0463061B1 Controlled release delivery device for macromolecular proteins |
| 06/09/1993 | EP0368920B1 Lectines fixing beta-d-galactoside |
| 06/09/1993 | EP0327648B1 Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient |
| 06/09/1993 | DE4140186A1 Oral dosage forms for peptide drugs - esp. insulin, contg. drug in gelatin matrix |
| 06/09/1993 | DE4140178A1 Oral administration forms for peptidic medicaments |
| 06/09/1993 | DE4140177A1 Oral administration forms for peptidic medicaments |
| 06/09/1993 | DE4140003A1 DNA encoding low mol.wt. glutaminase - used for glutamine isolation from human tissues or fluids for treating cancer and HIV |
| 06/08/1993 | US5218099 Pure polynucleotide complimentary to or the same as specified DNA sequence |
| 06/08/1993 | US5218096 Sweet, stable, nontoxic polysaccharide from treatment of mixture of lactose and starch or derivative with transferase enzyme |
| 06/08/1993 | US5218094 Neuronotrophic factor derived from mammalian brain tissue |
| 06/08/1993 | US5218093 Epidermal growth factor multimer and a carrier; wound healing agents |
| 06/08/1993 | US5218091 Glycolytic promoters for regulated protein expression: protease inhibitor |
| 06/08/1993 | US5218089 Retro-inverso analogues of thymopentin and the method for their synthesis |
| 06/08/1993 | US5218001 Inhibitors of the advanced glycosylation of proteins and methods of use therefor |
| 06/08/1993 | US5217959 Method of treating multiple sclerosis with phytic acid |
| 06/08/1993 | US5217958 1,2-hydroxy phosphonates and derivatives thereof |
| 06/08/1993 | US5217957 Cholecystokinin antagonists useful for treating depression |
| 06/08/1993 | US5217956 Composition and treatment with biologically active peptides and certain anions |
| 06/08/1993 | US5217955 Treating colon, prostate or breast cancer in mammals |
| 06/08/1993 | US5217954 Chelate agent added for oxidation resistance, aggregation resistance |
| 06/08/1993 | US5217953 Vasoactive intestinal peptide antagonist |
| 06/08/1993 | US5217952 Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof |
| 06/08/1993 | US5217951 Treatment of inflammation |
| 06/08/1993 | US5217950 Nisin compositions for use as enhanced, broad range bactericides |
| 06/08/1993 | US5217898 Expression of the P. falciparum transmission-blocking antigen in yeast |
| 06/08/1993 | US5217896 For diagnosis and treatment of humoral hypercalcemia |
| 06/08/1993 | US5217895 Neutralization of aids; diagnosis and(or) therapy |
| 06/08/1993 | US5217870 Monoclonal antibodies against CDX |
| 06/08/1993 | US5217864 Replication initiator protein complex and methods of use thereof |
| 06/08/1993 | US5217717 Method of making soybean Bowman-Birk inhibitor concentrate and use of same as a human cancer preventative and therapy |
| 06/08/1993 | US5217716 Aids therapy |
| 06/08/1993 | US5217714 Administering interleukins, then measuring blood concentration of adrenocortocotropic hormones, glucocorticoids or other hormones |
| 06/08/1993 | US5217713 Anticancer agents |
| 06/08/1993 | US5217648 In physiologically compatible oil |
| 06/08/1993 | CA1318985C Amino acid 1,2-diketo derivatives as renin inhibitors |
| 06/08/1993 | CA1318869C Method of removing n-terminal amino acid residues from eucaryotic polypeptide analogs and polypeptides produced thereby |
| 06/08/1993 | CA1318850C Pharmaceutical products |
| 06/07/1993 | CA2057213A1 Trophoblast interferon |
| 06/05/1993 | CA2084331A1 Method and composition for treating viral infections |
| 06/03/1993 | DE4139639A1 Synthetic aq. organ extract free of contaminating proteins etc. - contains aminoacid(s) peptide(s), sugar alcohol, carboxylic acid and alcohol, useful e.g. in cosmetics, for wound healing and to strengthen immunity |
| 06/03/1993 | CA2084231A1 Pharmaceutical composition containing egf for the treatment of bronchopulmonary diseases |
| 06/03/1993 | CA2083778A1 Variable region within fibroblast growth factor receptors that confers ligand specificity |
| 06/02/1993 | EP0544620A1 Macrocyclic lactams as inhibitors of atrial natriuretic factors (ANF)-degrading neutral endopeptidase (NEP) |
| 06/02/1993 | EP0544466A1 Tri-arginine insulins |
| 06/02/1993 | EP0544293A2 Process for the preparation of biologically active NGF by genetic engineering |
| 06/02/1993 | EP0543938A1 Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides |
| 06/02/1993 | EP0543902A1 Use of metalloporphyrins to potentiate aids therapy |
| 06/02/1993 | EP0521963A4 Crf analogs |
| 06/02/1993 | CN1072723A Tri-arginine insulins. |
| 06/02/1993 | CN1072687A Anti-alphab-integrin antibodies |
| 06/02/1993 | CN1072601A Use of combination of angiotensin-converting enzyme inhibitor and calcium antagonist for treatment of proteinuria |
| 06/01/1993 | USRE34271 Production of alpha-alpha cross-linked hemoglobins in high yield |
| 06/01/1993 | US5216133 Thermosensitive, trypsin, chymotrypsin and mercaptam sensitive, pure protein |
| 06/01/1993 | US5216132 Soluble t-cell antigen receptor chimeric antigens |
| 06/01/1993 | US5216131 Lymphocyte homing receptors |
| 06/01/1993 | US5216128 IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it |
| 06/01/1993 | US5216124 Analgesics |
| 06/01/1993 | US5216025 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 06/01/1993 | US5215969 Dopaminergic neurotrophic factor for treatment of Parkinson's disease |
| 06/01/1993 | US5215968 Hypotension agents and viricides |
| 06/01/1993 | US5215967 Aminoacid derivatives inhibiting renin |
| 06/01/1993 | US5215966 For treatment of hypertension, hyperaldosteronism and cardiac insufficiency |
| 06/01/1993 | US5215965 Treatment of inflammation |
| 06/01/1993 | US5215964 Treating aging, depression, anxiety, autoimmune diseases |
| 06/01/1993 | US5215963 Solubilization and purification of the active gastrin releasing peptide receptor |
| 06/01/1993 | US5215913 IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use |
| 06/01/1993 | US5215898 Cytotoxic protein from the yeast Pichia inositovora |
| 06/01/1993 | US5215895 Dna encoding a mammalian cytokine, interleukin-11 |
| 06/01/1993 | US5215893 Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| 06/01/1993 | US5215888 Kit for assaying the cellular integrity of blood platelets |
| 06/01/1993 | US5215746 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 06/01/1993 | US5215744 Methods for the treatment of tumors |
| 06/01/1993 | US5215743 Tumor necrosis factor formulations |
| 06/01/1993 | US5215741 Method for prevention of parasite infections |
| 06/01/1993 | CA1318619C Method of using eukaryotic expression vectors comprising the bk virus enhancer |
| 06/01/1993 | CA1318587C Sustained release growth hormone compositions for parenteral administration and their use |
| 06/01/1993 | CA1318586C Treatment of tumors with autologous lak cells, interleukin-2 and an ornithine decarboxylase inhibitor |
| 05/28/1993 | WO1993010795A1 Topical emollient for prevention and treatment of circulatory induced lesions |
| 05/28/1993 | CA2101169A1 Topical emollient for prevention and treatment of circulatory induced lesions |
| 05/28/1993 | CA2083232A1 Fibronectin-containing ophthalmic solution, method of manufacture of an ophthalmic solution, method of preserving an ophthalmic solution, and methods of treatment of ophthalmic wounds |
| 05/27/1993 | WO1993010244A1 Synthetic alpha-l-iduronidase and genetic sequences encoding same |
| 05/27/1993 | WO1993010243A1 Recombinant gastric rabbit lipase and pharmaceutical compositions |
| 05/27/1993 | WO1993010242A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
| 05/27/1993 | WO1993010236A1 Protein allergens of the species cynodon dactylon |
| 05/27/1993 | WO1993010235A1 Human il-4 mutant proteins |
| 05/27/1993 | WO1993010234A1 Therapy of central nervous system by genetically modified cells |
| 05/27/1993 | WO1993010233A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor |
| 05/27/1993 | WO1993010231A1 Collagen-like polypeptides |
| 05/27/1993 | WO1993010229A1 Fusion proteins comprising mgf and il-3 |
| 05/27/1993 | WO1993010228A1 Dna encoding a glycine transporter and uses thereof |
| 05/27/1993 | WO1993010225A1 Protease vaccine against heartworm |
| 05/27/1993 | WO1993010221A1 Chimeric murine/human anti-idiotype monoclonal antibodies |
| 05/27/1993 | WO1993010220A1 Soluble mhc molecules and their uses |
| 05/27/1993 | WO1993010219A1 Cellular composition for the treatment of human or animal organisms |